From the U.S. Department of Health & Human Services, Administration for Strategic Preparedness and Response
Press Release dated October 4th, 2022
HHS purchases drug for use in radiological and nuclear emergencies
As part of long-standing, ongoing efforts to be better prepared to save lives following radiological and nuclear emergencies, the U.S. Department of Health and Human Services is purchasing a supply of the drug Nplate from Amgen USA Inc; Nplate is approved to treat blood cell injuries that accompany acute radiation syndrome in adult and pediatric patients (ARS).
No mention of how many doses but the budget is $290 million...
This is under a program started in 2004 so nothing new but why now? Why $290M worth?
Leave a comment